menu

Results From the EMPULSE Trial: Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospi

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Analysis from the ACC 2022 - Integrating Complex Data into Clinical Practice

Results From the EMPULSE Trial: Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized For Acute Heart Failure

Minute CME/CE™
ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Take 1 Minute Challenge
1 Minute Challenge Completed
1.50 credits
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American College of Cardiology 71st Annual Scientific Session & Expo (ACC.22).

  • Target Audience

    This activity has been designed to meet the educational needs of academic and community-based cardiologists, critical care, emergency medicine, hospital medicine, interventional radiology, and vascular medicine specialists. It also includes nurses, nurse practitioners, physician assistants, pharmacists, and any HCPs involved in the care and/or treatment of patients with cardiovascular disease.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    1. Evaluate recent practice-changing data that can be applied to practice and patients
    2. Apply recently presented data into clinical practice to expand treatment options and improve outcomes for patients
    3. Discuss new data on novel agents and therapeutic approaches for patients with application in the community setting
  • Accreditation and Credit Designation Statements

     In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 1.5 hours of Nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 1.5 hours/0.15 CEUs of Pharmacy contact hours.

    The Universal Activity Number for this program is UAN JA0006235-0000-22-010-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. 

    The following faculty has reported relationships with ineligible companies:

    Deepak L. Bhatt, MD, MPH, faculty for this educational event, has received research funding from Abbott, Afimmune, Aker Biomarine, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CSL Behring, Eisai, Ethicon, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, and 89Bio.

    Milind Y. Desai, MD, MBA, faculty for this educational event, has received consulting fees from Bristol Myers Squibb, Medtronic, and Caristo Diagnostic, and research funding from Bristol Myers Squibb.

    G. Michael Felker, MD, MHS, FACC, FAHA, FHFSA, faculty for this educational event, has received consulting fees from Novartis, Amgen, BMS, Cytokinetics, Medtronic, Cardionomic, Boehringer-Ingelheim, American Regent, Abbott, Astra-Zeneca, Reprieve, Myovant, Sequana, Windtree Therapuetics, and Whiteswell; and research funding from Amgen, Bayer, BMS,  Merck, Cytokinetics, CSL.

    Gerasimos Filippatos, MD, DHC, FESC, FHFA, FHFSA(h), faculty for this educational event, has received consulting fees from Amgen, Bayer, Boehringer Ingelheim, Medtronic, Novartis, Servier, and Vifor.

    Mikhail Kosiborod, MD, FACC, FAHA, faculty for this educational event, has received consulting fees from Alnylam, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Eli Lilly, Esperion Therapeutics, Janssen, Lexicon, Merck (Diabetes and Cardiovascular), Novo Nordisk, Pharmacosmos, Sanofi, Vifor Pharma; and research funding from AstraZeneca and Boehringer Ingelheim.

    Manesh R. Patel, MD, faculty for this educational event, has received consulting fees from Bayer, Janssen, Novartis, and research funding from AstraZeneca, Bayer, Janssen, Mytonomy, and Procyrion.

    Mehdi H. Shishehbor, DO, MPH, PhD, faculty for this educational event, has ownership interest in ANT, received consulting fees from Abbott Vascular, Medtronics, BSC, Terumo, Philips, and research funding from Inari, Abbott, Medtronics, Terumo, BSC.

    Dylan L. Steen, MD, MS, faculty for this educational event, has received consulting fees from Sanofi; has ownership interest in High Enroll, LLC; is an employee of an ineligible company High Enroll, LLC; and received research funding from The Kroger Company.

    Mark Svet, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.

    All the relevant financial relationships for these individuals have been mitigated.

    The following reviewers/planners have reported no relationships with ineligible companies:

    Prerna Poojary, PhD, planner for this educational event, has no relevant financial relationships with ineligible companies.

    William Mencia, MD, FACEHP, CHCP, planner for this educational event, has no relevant financial relationships with ineligible companies.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and TotalCME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Acknowledgement

    This activity is supported by independent educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC, Cytokinetics, Inc., and Bayer.

    Jointly provided by Global Learning Collaborative (GLC) and TotalCME, Inc.

  • Fee Statement

    This activity is FREE to all participants.

  • Instructions for Completion

    During the period 04/25/2022 through 04/25/2023, registered participants wishing to receive continuing education credit for this activity must follow these steps:

    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Customize your experience based on your profession
Profession
Registration is a short process and your information will be kept safe.
Schedule6 Dec 2022